Table 3 The mean annual costs in RRMS patients using natalizumab and rituximab
Costs | natalizumab | rituximab | ||
|---|---|---|---|---|
PPP $ | Percentage | PPP $ | Percentage | |
Direct Medical Costs | ||||
 Physicians’ Visits | 258.00 | 0.74 | 89.90 | 1.82 |
 Main Medicines | 32,942.24 | 94.36 | 2,038.51 | 41.33 |
 Supplementary Medicines | 695.69 | 1.99 | 421.64 | 8.55 |
 Laboratory Tests | 267.18 | 0.77 | 220.63 | 4.47 |
 MRIs | 508.09 | 1.46 | 1,457.97 | 29.56 |
 Physiotherapy & Other Services Costs | 0.00 | 0.00 | 647.27 | 13.12 |
 Hospitalization & Surgeries | 241.60 | 0.69 | 56.04 | 1.14 |
 Total | 34,912.80 | 96.82 | 4,931.96 | 91.34 |
Direct Non-Medical Costs | ||||
 Transportation | 441.72 | 66.35 | 27.94 | 67.94 |
 Accommodation | 53.14 | 7.98 | 0.00 | 0.00 |
 Meals | 53.14 | 7.98 | 0.00 | 0.00 |
 Purchasing Auxiliary Tools | 117.70 | 17.68 | 13.18 | 32.06 |
 Total | 665.70 | 1.85 | 41.12 | 0.76 |
Indirect Costs | ||||
 Income Lost due to Outpatient Visits | 282.83 | 58.97 | 254.72 | 59.76 |
 Income Lost due to Hospitalization | 79.27 | 16.53 | 64.40 | 15.11 |
 Patient’s Family Costs | 117.48 | 24.50 | 107.08 | 25.13 |
 Total | 479.58 | 1.33 | 426.20 | 7.89 |
Total Costs | 36,058.08 | 100.00 | 5,399.28 | 100.00 |